Genomic screening in children: BabyScreen+
Gene: CASQ2
ClinGen: 'strong actionability' both for adult and paediatric patients. Treatment: beta blockers first line; ICD. There are also numerous known arrhythmia triggers which can be avoided.
The mean age of onset of symptoms (usually a syncopal episode) of CPVT is between age seven and twelve years; onset as late as the fourth decade of life has been reported. Nearly 60% of patients have at least one syncopal episode before age 40. If untreated, CPVT is highly lethal, as approximately 30% of genetically affected individuals experience at least one cardiac arrest and up to 80% one or more syncopal spells. In untreated patients, the 8-year fatal or near-fatal event rates of 25% have been reported. Sudden death may be the first manifestation of the disease.Created: 14 Aug 2025, 12:47 p.m. | Last Modified: 14 Aug 2025, 12:47 p.m.
Panel Version: 0.15
Sources: Expert listCreated: 14 Aug 2025, 12:41 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Ventricular tachycardia, catecholaminergic polymorphic, 2, MIM# 611938
Tag cardiac tag was added to gene: CASQ2. Tag treatable tag was added to gene: CASQ2.
Gene: casq2 has been classified as Green List (High Evidence).
Phenotypes for gene: CASQ2 were changed from to Ventricular tachycardia, catecholaminergic polymorphic, 2, MIM# 611938
Gene: casq2 has been classified as Green List (High Evidence).
gene: CASQ2 was added gene: CASQ2 was added to Genomic screening in children: BabyScreen+. Sources: Expert list Mode of inheritance for gene: CASQ2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Review for gene: CASQ2 was set to GREEN